Skip to main content
Sansure Biotech Inc. logo

Sansure Biotech Inc. — Investor Relations & Filings

Ticker · 688289 ISIN · CNE1000043J1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2021-10-21 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688289

About Sansure Biotech Inc.

https://www.sansureglobal.com/

Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.

Recent filings

Filing Released Lang Actions
圣湘生物科技股份有限公司独立董事关于第一届董事会2021年第八次临时会议相关事宜的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's board meeting, specifically regarding a restricted stock incentive plan and a share repurchase plan. It includes detailed assessments of the legality, compliance, and rationale behind these proposals. The content focuses on governance and management decisions rather than financial results or regulatory filings. The document length is 4555 characters, which is relatively short but contains substantive content rather than just an announcement. The key topics are related to board decisions on stock incentives and share repurchase, which aligns with management or board information disclosures. Therefore, the document fits best under Board/Management Information (MANG) as it announces and explains board meeting decisions and opinions on management proposals.
2021-10-21 Chinese
圣湘生物科技股份有限公司第一届董事会2021年第八次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of 圣湘生物科技股份有限公司 (Shengxiang Bio-tech Co., Ltd.) held on October 21, 2021. It details the approval of various proposals related to a restricted stock incentive plan, authorization requests for the shareholders' meeting, a share repurchase plan, and amendments to the company bylaws. The document is a formal announcement of board decisions and upcoming shareholder meeting proposals, not a full report or financial statement. It does not contain financial data or detailed management discussion but rather governance and management decisions. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2021-10-21 Chinese
圣湘生物科技股份有限公司关于持股5%以上股东部分股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a shareholder holding more than 5% of the company's shares. It details the number of shares pledged, the percentage of total shares, and related information about the pledge. There is no financial report, earnings data, or management discussion. The document is a regulatory disclosure about a major shareholder's share pledge, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on this shareholding pledge event, confirming it is not a full report or announcement of a report publication.
2021-09-28 Chinese
圣湘生物科技股份有限公司关于持股5%以上股东股份被司法冻结的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the judicial freezing of shares held by a shareholder owning more than 5% of the company's stock. It details the legal circumstances, the number of shares frozen, and the impact on company control and operations. There is no financial data, no report attached or referenced as being published, and no mention of annual or interim reports. The content fits the definition of a Major Shareholding Notification (MRQ), specifically about a significant shareholder's shares being frozen due to legal reasons. Therefore, the appropriate classification is MRQ.
2021-09-16 Chinese
圣湘生物科技股份有限公司关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 圣湘生物科技股份有限公司 regarding the use of temporarily idle raised funds for cash management. It details the board and supervisory committee approvals, investment scope, risk controls, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial data but rather describes a corporate decision and related approvals. It is a regulatory announcement about capital usage rather than a financial report or earnings release. The document length is 3492 characters, which is relatively short and consistent with an announcement. Therefore, it fits best under Capital/Financing Update (CAP) as it concerns the use of raised capital for cash management purposes.
2021-09-16 Chinese
圣湘生物科技股份有限公司第一届监事会2021年第六次临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting of 圣湘生物科技股份有限公司. It details the meeting date, attendance, agenda, and voting results regarding the use of temporarily idle raised funds for cash management. The content is a meeting resolution announcement rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. The document length is short (675 characters), and it is an official announcement of a board decision. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2021-09-16 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.